0001214659-20-008371.txt : 20201002 0001214659-20-008371.hdr.sgml : 20201002 20201002161506 ACCESSION NUMBER: 0001214659-20-008371 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20200930 FILED AS OF DATE: 20201002 DATE AS OF CHANGE: 20201002 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: BARLIANT RONALD CENTRAL INDEX KEY: 0001288093 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-35798 FILM NUMBER: 201220163 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: HUMANIGEN, INC CENTRAL INDEX KEY: 0001293310 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 770557236 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 533 AIRPORT BLVD. STREET 2: SUITE 400 CITY: BURLINGAME STATE: CA ZIP: 94010 BUSINESS PHONE: 650.243.3100 MAIL ADDRESS: STREET 1: 533 AIRPORT BLVD. STREET 2: SUITE 400 CITY: BURLINGAME STATE: CA ZIP: 94010 FORMER COMPANY: FORMER CONFORMED NAME: KALOBIOS PHARMACEUTICALS INC DATE OF NAME CHANGE: 20040609 4 1 marketforms-49822.xml PRIMARY DOCUMENT X0306 4 2020-09-30 0001293310 HUMANIGEN, INC HGEN 0001288093 BARLIANT RONALD C/O HUMANIGEN, INC. 533 AIRPORT BOULEVARD, SUITE 400 BURLINGAME CA 94010 true false false false Stock Option (Right to Buy) 10.64 2020-09-30 4 A false 1803 8.04 A 2020-09-30 2030-09-29 Common Stock 1803 1803 D The stock option was granted to Mr. Barliant in lieu of $14,500 of cash compensation otherwise payable to Mr. Barliant in respect of his services as a director during the third quarter of 2020. /s/ Cameron Durrant, Attorney-In-Fact 2020-10-02